Yanhong Gu, Tianzhu Qiu, Lu Mingjie, Yuwen Dong. "Fruquintinib in combination with camrelizumab, paclitaxel liposome, and nedaplatin as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Updated results from a single-arm, phase II study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e16070